Restoration of left ventricular geometry and improvement of left ventricular function in a rodent model of chronic ischemic cardiomyopathy

Journal of Thoracic and Cardiovascular Surgery

Volumn 137, Issue 1, 2009, Pages 180-187

  Yu, Jiashing ^a   Christman, Karen L ^a   Chin, Eric ^b   Sievers, Richard E ^b   Saeed, Maythem ^b   Lee, Randall J ^a,b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALGINIC ACID; BIOPOLYMER; FIBRIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; ECHOCARDIOGRAPHY; FEMALE; GEOMETRY; HEART INFARCTION; HEART INFARCTION SIZE; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE PERFORMANCE; HEART SURGERY; HEART VENTRICLE SIZE; HEART VENTRICLE WALL; ISCHEMIC HEART DISEASE; NONHUMAN; PRIORITY JOURNAL; RAT; TISSUE ENGINEERING;

ALGINATES; ANIMALS; BIOCOMPATIBLE MATERIALS; CHRONIC DISEASE; DISEASE MODELS, ANIMAL; FIBRIN TISSUE ADHESIVE; GLUCURONIC ACID; HEART VENTRICLES; HEXURONIC ACIDS; MYOCARDIAL ISCHEMIA; RATS; RATS, SPRAGUE-DAWLEY; TISSUE ADHESIVES; TISSUE ENGINEERING; VENTRICULAR FUNCTION, LEFT;

EID: 58249087159     PISSN: 00225223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jtcvs.2008.08.036     Document Type: Article

References (39)

1. Braunwald E., and Bristow M.R. Congestive heart failure: fifty years of progress. Circulation 102 suppl 4 (2000) IV14-IV23
2. Hunt S.A. ACC/AHA 2005 guideline update for the diagnosis and management of chronic heart failure in the adult: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 47 (2006) 1503-1505
3. el Oakley R.M., Yonan N.A., Simpson B.M., and Deiraniya A.K. Extended criteria for cardiac allograft donors: a consensus study. J Heart Lung Transplant 15 (1996) 255-295
4. Christman K.L., and Lee R.J. Biomaterials for the treatment of myocardial infarction. J Am Coll Cardiol 48 (2006) 907-913
5. Zammaretti P., and Jaconi M. Cardiac tissue engineering: regeneration of the wounded heart. Curr Opin Biotechnol 15 (2004) 430-434
6. Huang N.F., Lee R.J., and Li S. Chemical and physical regulation of stem cells and progenitor cells: potential for cardiovascular tissue engineering. Tissue Eng 13 (2007) 1809-1823
7. Dai W., Wold L.E., Dow J.S., and Kloner R.A. Thickening of the infarcted wall by collagen injection improves left ventricular function in rats: a novel approach to preserve cardiac function after myocardial infarction. J Am Coll Cardiol 46 (2005) 714-719
8. Kofidis T., de Bruin J.L., Hoyt G., Lebl D.R., Tanaka M., Yamane T., et al. Injectable bioartificial myocardial tissue for large-scale intramural cell transfer and functional recovery of injured heart muscle. J Thorac Cardiovasc Surg 128 (2004) 571-578
9. Christman K.L., Fok H.H., Sievers R.E., Fang Q., and Lee R.J. Fibrin glue alone and skeletal myoblasts in a fibrin scaffold preserve cardiac function after myocardial infarction. Tissue Eng 10 (2004) 403-409
10. Awad H.A., Wickham M.Q., Leddy H.A., Gimble J.M., and Guilak F. Chondrogenic differentiation of adipose-derived adult stem cells in agarose, alginate, and gelatin scaffolds. Biomaterials 25 (2004) 3211-3222
11. Huang N.F., Sievers R.E., Park J.S., Fang Q., Li S., and Lee R.J. A rodent model of myocardial infarction for testing the efficacy of cells and polymers for myocardial reconstruction. Nat Protoc 1 (2006) 1596-1609
12. Litwin S.E., Katz S.E., Morgan J.P., and Douglas P.S. Serial echocardiographic assessment of left ventricular geometry and function after large myocardial infarction in the rat. Circulation 89 (1994) 345-354
13. Christman K.L., Vardanian A.J., Fang Q., Sievers R.E., Fok H.H., and Lee R.J. Injectable fibrin scaffold improves cell transplant survival, reduces infarct expansion, and induces neovasculature formation in ischemic myocardium. J Am Coll Cardiol 44 (2004) 654-660
14. Li R.K., Yau T.M., Weisel R.D., Mickle D.A., Sakai T., Choi A., et al. Construction of a bioengineered cardiac graft. J Thorac Cardiovasc Surg 119 (2000) 368-375
15. Kofidis T., Akhyari P., Boublik J., Theodorou P., Martin U., Ruhparwar A., et al. In vitro engineering of heart muscle: artificial myocardial tissue. J Thorac Cardiovasc Surg 124 (2002) 63-69
16. Kellar R.S., Landeen L.K., Shepherd B.R., Naughton G.K., Ratcliffe A., and Williams S.K. Scaffold-based three-dimensional human fibroblast culture provides a structural matrix that supports angiogenesis in infarcted heart tissue. Circulation 104 (2001) 2063-2068
17. Drury J.L., and Mooney D.J. Hydrogels for tissue engineering: scaffold design variables and applications. Biomaterials 24 (2003) 4337-4351
18. Butler D.L., Goldstein S.A., and Guilak F. Functional tissue engineering: the role of biomechanics. J Biomech Eng 122 (2000) 570-575
19. Jackson B.M., Gorman III J.H., Salgo I.S., Moainie S.L., Plappert T., St John-Sutton M., et al. Border zone geometry increases wall stress after myocardial infarction: contrast echocardiographic assessment. Am J Physiol Heart Circ Physiol 284 (2003) H475-H479
20. Wall S.T., Walker J.C., Healy K.E., Ratcliffe M.B., and Guccione J.M. Theoretical impact of the injection of material into the myocardium: a finite element model simulation. Circulation 114 (2006) 2627-2635
21. Zhu B.Q., Sievers R.E., Browne A.E., Lee R.J., Chatterjee K., Grossman W., et al. Comparative effects of aspirin with ACE inhibitor or angiotensin receptor blocker on myocardial infarction and vascular function. J Renin Angiotensin Aldosterone Syst 4 (2003) 31-37
22. Murohara T., Guo J.P., and Lefer A.M. Cardioprotection by a novel recombinant serine protease inhibitor in myocardial ischemia and reperfusion injury. J Pharmacol Exp Ther 274 (1995) 1246-1253
23. Fu Y., Wang Z., Chen W.L., Moore P.K., and Zhu Y.Z. Cardioprotective effects of nitric oxide-aspirin in myocardial ischemia-reperfused rats. Am J Physiol Heart Circ Physiol 293 (2007) H1545-H1552
24. Ferdinandy P., Schulz R., and Baxter G.F. Interaction of cardiovascular risk factors with myocardial ischemia/reperfusion injury, preconditioning, and postconditioning. Pharmacol Rev 59 (2007) 418-5
25. Gorlin R., Klein M.D., and Sullivan J.M. Prospective correlative study of ventricular aneurysm. Mechanistic concept and clinical recognition. Am J Med 42 (1967) 512-531
26. Walker J.C., Ratcliffe M.B., Zhang P., Wallace A.W., Hsu E.W., Saloner D.A., et al. Magnetic resonance imaging-based finite element stress analysis after linear repair of left ventricular aneurysm. J Thorac Cardiovasc Surg 135 (2008) 1094-1102
27. Davis M.E., Hsieh P.C., Grodzinsky A.J., and Lee R.T. Custom design of the cardiac microenvironment with biomaterials. Circ Res 97 (2005) 8-15
28. Hall H., Baechi T., and Hubbell J.A. Molecular properties of fibrin-based matrices for promotion of angiogenesis in vitro. Microvasc Res 62 (2001) 315-326
29. Bootle-Wilbraham C.A., Tazzyman S., Thompson W.D., Stirk C.M., and Lewis C.E. Fibrin fragment E stimulates the proliferation, migration and differentiation of human microvascular endothelial cells in vitro. Angiogenesis 4 (2001) 269-275
30. Soldi R., Mitola S., Strasly M., Defilippi P., Tarone G., and Bussolino F. Role of alphavbeta3 integrin in the activation of vascular endothelial growth factor receptor-2. EMBO J 18 (1999) 882-892
31. Vandervelde S., van Luyn M.J., Tio R.A., and Harmsen M.C. Signaling factors in stem cell-mediated repair of infarcted myocardium. J Mol Cell Cardiol 39 (2005) 363-376
32. Augst A.D., Kong H.J., and Mooney D.J. Alginate hydrogels as biomaterials. Macromol Biosci 6 (2006) 623-633
33. Frangogiannis N.G. Chemokines in the ischemic myocardium: from inflammation to fibrosis. Inflamm Res 53 (2004) 585-595
34. Hotary K.B., Yana I., Sabeh F., Li X.Y., Holmbeck K., Birkedal-Hansen H., et al. Matrix metalloproteinases (MMPs) regulate fibrin-invasive activity via MT1-MMP-dependent and -independent processes. J Exp Med 195 (2002) 295-308
35. Yao L., Swartz D.D., Gugino S.F., Russell J.A., and Andreadis S.T. Fibrin-based tissue-engineered blood vessels: differential effects of biomaterial and culture parameters on mechanical strength and vascular reactivity. Tissue Eng 11 (2005) 991-1003
36. Chekanov V.S., Nikolaychik V.V., Rieder M.A., Tchekanov G.V., Hernandez I., Eisenstein R., et al. Autologous biological glue and aprotinin prevent ischemia in latissimus dorsi muscle after mobilization. Basic Appl Myol 8 (1998) 211-219
37. LeRoux M.A., Guilak F., and Setton L.A. Compressive and shear properties of alginate gel: effects of sodium ions and alginate concentration. J Biomed Mater Res 47 (1999) 46-53
38. Smidsrod O., and Skjak-Braek G. Alginate as immobilization matrix for cells. Trends Biotechnol 8 (1990) 71-78
39. Alsberg E., Kong H.J., Hirano Y., Smith M.K., Albeiruti A., and Mooney D.J. Regulating bone formation via controlled scaffold degradation. J Dent Res 82 (2003) 903-908